These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38223124)

  • 1. The use of cardiac magnetic resonance in hypertrophic cardiomyopathy over the past 10 years [2013-2023]: a CiteSpace-based bibliometric analysis.
    Hu M; Shen Y; Song Y; Li S; Yang P; Kan A; Fang Q; Peng Y; Ren H; Zhang Y; Gong L
    Quant Imaging Med Surg; 2024 Jan; 14(1):566-578. PubMed ID: 38223124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global research trends of hypertrophic cardiomyopathy from 2000 to 2022: Insights from bibliometric analysis.
    Zheng X; He Z; Li M; Jia Z
    Front Cardiovasc Med; 2023; 10():1039098. PubMed ID: 36818354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Maron MS
    J Cardiovasc Magn Reson; 2012 Feb; 14(1):13. PubMed ID: 22296938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.
    Maron MS
    J Cardiovasc Transl Res; 2009 Dec; 2(4):415-25. PubMed ID: 20560000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.
    Kamal MU; Riaz IB; Janardhanan R
    Cardiol J; 2016; 23(3):250-63. PubMed ID: 27064795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
    Choi HM; Kim KH; Lee JM; Yoon YE; Lee SP; Park EA; Lee W; Kim YJ; Cho GY; Sohn DW; Kim HK
    Heart; 2015 Jun; 101(11):870-6. PubMed ID: 25897040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The association between cardiac mr feature tracking strain and myocardial late gadolinium enhancement in patients with hypertrophic cardiomyopathy].
    Ozden O; Unlu S; Kilic DI; Sherif SA; Opan S; Kemal HS; Ozmen E; Tuner H; Bingol G; Barutcu A; Nasifov M; Bakan S; Goktekin O
    Kardiologiia; 2023 Feb; 63(2):52-58. PubMed ID: 36880144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance.
    Huurman R; van der Velde N; Schinkel AFL; Hassing HC; Budde RPJ; van Slegtenhorst MA; Verhagen JMA; Hirsch A; Michels M
    Eur Heart J Cardiovasc Imaging; 2022 Aug; 23(9):1144-1154. PubMed ID: 35670722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management.
    Licordari R; Trimarchi G; Teresi L; Restelli D; Lofrumento F; Perna A; Campisi M; de Gregorio C; Grimaldi P; Calabrò D; Costa F; Versace AG; Micari A; Aquaro GD; Di Bella G
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study.
    Rowin EJ; Maron MS; Adler A; Albano AJ; Varnava AM; Spears D; Marsy D; Heitner SB; Cohen E; Leong KMW; Winters SL; Martinez MW; Koethe BC; Rakowski H; Maron BJ
    Heart Rhythm; 2022 May; 19(5):782-789. PubMed ID: 34933112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy].
    Maron MS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1057-63. PubMed ID: 20193172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy.
    Cavus E; Muellerleile K; Schellert S; Schneider J; Tahir E; Chevalier C; Jahnke C; Radunski UK; Adam G; Kirchhof P; Blankenberg S; Lund GK; Avanesov M; Patten M
    Clin Res Cardiol; 2021 Nov; 110(11):1757-1769. PubMed ID: 33779809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural language processing for identification of hypertrophic cardiomyopathy patients from cardiac magnetic resonance reports.
    Dewaswala N; Chen D; Bhopalwala H; Kaggal VC; Murphy SP; Bos JM; Geske JB; Gersh BJ; Ommen SR; Araoz PA; Ackerman MJ; Arruda-Olson AM
    BMC Med Inform Decis Mak; 2022 Oct; 22(1):272. PubMed ID: 36258218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge Structure and Emerging Trends of Telerehabilitation in Recent 20 Years: A Bibliometric Analysis
    Zheng J; Hou M; Liu L; Wang X
    Front Public Health; 2022; 10():904855. PubMed ID: 35795695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline and Longitudinal Imaging of Hypertrophic Cardiomyopathy in the Era of Emerging Therapeutics.
    Altibi A; Alani A; Zhao Y; Masri A
    Curr Cardiol Rep; 2023 Jun; 25(6):583-595. PubMed ID: 37103749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.
    Rodrigues JC; Rohan S; Ghosh Dastidar A; Harries I; Lawton CB; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Paton JF; Nightingale AK; Manghat NE
    Eur Radiol; 2017 Mar; 27(3):1125-1135. PubMed ID: 27368925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world clinical validity of cardiac magnetic resonance tissue tracking in primitive hypertrophic cardiomyopathy.
    Palumbo P; Masedu F; De Cataldo C; Cannizzaro E; Bruno F; Pradella S; Arrigoni F; Valenti M; Splendiani A; Barile A; Giovagnoni A; Masciocchi C; Di Cesare E
    Radiol Med; 2021 Dec; 126(12):1532-1543. PubMed ID: 34894317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy.
    Rowin EJ; Maron MS
    Arrhythm Electrophysiol Rev; 2016; 5(3):197-202. PubMed ID: 28116085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.